Please select the option that best describes you:
Topics:
Head and Neck Cancers • Medical Oncology
How would you manage a local recurrence at the skull base after concurrent chemoRT for locally advanced nasopharyngeal carcinoma?
Given not surgical candidate and within 1 year of chemoRT (recurrence within RT field), would you repeat chemoRT, RT alone, or systemic therapy alone? What about if the patient is not a candidate for high dose cisplatin?
Answer from: Medical Oncologist at Community Practice
Available data does not support re-irradiation when the recurrence is less than 1 year after primary treatment.
In this case I would favor systemic therapy, either with platinum-gemcitabine or Pembrolizumab if pts tumor is PD-L1 positive.
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
I agree with Cesar. I would also get molecular profiling (Foundation One or similar) because there may be trials available in the future.